Home
/
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA)
Stock Analysis
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA)
TEVA · Technology · Software
33.69
-2.71%
TrendConstructive
MomentumNeutral
52W Position87% of 52W range
Updated: 2026-06-16 10:53 UTC
WOI Investment Thesis
Constructive
Confidence74%
RiskElevated
Timeframe1–3M
Break above 36.34 improves confirmation; below 33.55 weakens the setup.
Bull37.69
Base36.34
Bear33.55
Decision Levels
Resistance36.34
Support33.55
BreakoutAbove 36.34
Invalidationlosing 33.55 would weaken the current structure.
Upside Target37.69
Expected36.34
What's Driving TEVA?
📈 Technical recovery is improving
Momentum is Neutral. The main decision zone is framed by resistance near 36.34 and support near 33.55.
💼 Business quality remains relevant
The setup is supported by the latest fundamentals snapshot. Use the Business Lens card for revenue, profitability and balance sheet context.
⚠️ Key risk remains
losing 33.55 would weaken the current structure.
Full Analysis Workspace
Technical Setup
🔺 Technical Setup
Breakout Watch
Downtrend line not broken yet · score 0
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 33.55 and resistance around 36.85. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Business Lens
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Financial context is mixed
📈 Growth: Moderate
💰 Profit: Improving
💵 Cash: Pressured
🛡 Balance: Stretched
• Quarterly revenue is still growing, but the pace is cooling from earlier highs.
• Quarterly profitability is improving as earnings recover from an earlier soft patch.
🏢 Company
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Related Stocks
Compare with related stocks
Same sector and industry ideas for deeper research
Note: This is an algorithmic technical snapshot, not financial advice.